ebomi
Colour theme
Sign in
Insider · CIK 0001253886

Enright Patrick G

CIK 0001253886 Name as filed on the most recent filing

Filed as Enright Patrick G (105)

366 transaction lines · from 105 filings · filed 2005-02-09 to 2026-02-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

321 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-02-05 P, Open-market purchase Veradermics, IncMANE 2 lines 18,275,000, acquired Open Form 4 filing 0001628280-26-005904
2026-02-04 S, Open-market sale Rapid Micro Biosystems, Inc.RPID 190,091, disposed Open Form 4 filing 0001193125-26-041248
2026-02-03 S, Open-market sale Rapid Micro Biosystems, Inc.RPID 116,641, disposed Open Form 4 filing 0001193125-26-036387
2026-02-02 S, Open-market sale Rapid Micro Biosystems, Inc.RPID 116,765, disposed Open Form 4 filing 0001193125-26-036387
2026-01-30 S, Open-market sale Rapid Micro Biosystems, Inc.RPID 209,001, disposed Open Form 4 filing 0001193125-26-036387
2026-01-23 S, Open-market sale Rapid Micro Biosystems, Inc.RPID 31,451, disposed Open Form 4 filing 0001193125-26-036387
2025-12-11 P, Open-market purchase Vera Therapeutics, Inc.VERA 249,985, acquired Open Form 4 filing 0001193125-25-319649
2025-10-09 P, Open-market purchase Zenas BioPharma, Inc.ZBIO 2 lines 2,250,027, acquired Open Form 4 filing 0001193125-25-238326
2025-06-24 P, Open-market purchase Vera Therapeutics, Inc.VERA 2 lines 907,635, acquired Open Form 4 filing 0000950170-25-090110
2025-06-23 P, Open-market purchase Vera Therapeutics, Inc.VERA 2 lines 4,369,676, acquired Open Form 4 filing 0000950170-25-090110
2024-09-27 P, Open-market purchase BioAge Labs, Inc.BIOA 7,200,000, acquired Open Form 4 filing 0001415889-24-024046
2024-09-16 P, Open-market purchase Zenas BioPharma, Inc.ZBIO 7,480,000, acquired Open Form 4 filing 0001104659-24-100333
2023-11-07 P, Open-market purchase Lexeo Therapeutics, Inc.LXEO 4,999,995, acquired Open Form 4 filing 0001209191-23-054904
2023-08-14 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 171,455, disposed Open Form 4 filing 0001765581-23-000078
2023-02-06 P, Open-market purchase Vera Therapeutics, Inc.VERA 11,999,995, acquired Open Form 4 filing 0000899243-23-004345
2022-11-22 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 3 lines 1,049,264, disposed Open Form 4 filing 0001765581-22-000126
2022-08-08 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 165,883, disposed Open Form 4 filing 0001765581-22-000084
2022-04-19 P, Open-market purchase Inozyme Pharma, Inc.INZY 4,999,950, acquired Open Form 4 filing 0000899243-22-015325
2022-02-10 P, Open-market purchase Vera Therapeutics, Inc.VERA 4,999,995, acquired Open Form 4 filing 0000899243-22-013596
2022-02-02 P, Open-market purchase Sierra Oncology, Inc.SRRA 4,725,000, acquired Open Form 4 filing 0000899243-22-004271
2021-07-19 P, Open-market purchase Rapid Micro Biosystems, Inc.RPID 3,000,000, acquired Open Form 4 filing 0000899243-21-029105
2021-05-18 P, Open-market purchase Vera Therapeutics, Inc.VERA 9,999,990, acquired Open Form 4 filing 0001209191-21-033809
2021-05-11 P, Open-market purchase Talaris Therapeutics, Inc.TALS 3,995,000, acquired Open Form 4 filing 0000899243-21-019166
2020-11-12 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 3 lines 1,456,738, disposed Open Form 4 filing 0001765581-20-000120
2020-10-20 P, Open-market purchase Eargo, Inc.EAR 4,199,994, acquired Open Form 4 filing 0000899243-20-029109
2020-08-28 S, Open-market sale Molecular Templates, Inc.MTEM 2 lines 37,568, disposed Open Form 4 filing 0000899243-20-023790
2020-07-28 P, Open-market purchase Inozyme Pharma, Inc.INZY 10,000,000, acquired Open Form 4 filing 0000899243-20-020572
2020-07-10 P, Open-market purchase 89bio, Inc.ETNB 2,999,975, acquired Open Form 4 filing 0000899243-20-019123
2020-05-27 S, Open-market sale Aimmune Therapeutics, Inc.AIMT Not reported Open Form 4 filing 0000899243-20-014612
2020-03-18 P, Open-market purchase Aimmune Therapeutics, Inc.AIMT 179,345, acquired Open Form 4 filing 0000899243-20-009016
2020-03-17 P, Open-market purchase Aimmune Therapeutics, Inc.AIMT 2 lines 1,240,701, acquired Open Form 4 filing 0000899243-20-009016
2020-01-10 P, Open-market purchase Aptinyx Inc.APTX 2 lines 785,001, acquired Open Form 4 filing 0001567619-20-001010
2019-11-25 P, Open-market purchase Molecular Templates, Inc.MTEM 7,500,000, acquired Open Form 4 filing 0000899243-19-028574
2019-11-25 P, Open-market purchase Molecular Templates, Inc.MTEM 7,496,000, acquired Open Form 4 filing 0000899243-19-028242
2019-11-11 P, Open-market purchase 89bio, Inc.ETNB 9,200,000, acquired Open Form 4 filing 0000899243-19-027219
2019-08-09 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 98,481, disposed Open Form 4 filing 0001765581-19-000082
2018-11-02 P, Open-market purchase Axonics Modulation Technologies, Inc.AXNX 7,999,995, acquired Open Form 4 filing 0000899243-18-028081
2018-09-21 P, Open-market purchase Molecular Templates, Inc.MTEM 2,007,500, acquired Open Form 4 filing 0001209191-18-052151
2018-09-06 S, Open-market sale Jazz Pharmaceuticals plcJAZZ 1,196,565, disposed Open Form 4 filing 0001232524-18-000167

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 35
  • Open-market sale 286
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. ENRIGHT PATRICK G, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001253886

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.